Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Disc Medicine, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 152
- +22 vs. Q3 2024
- Shares held
- 26.6M
- −726.8K (−2.7%) vs. Q3 2024
- Total value
- $1.68B
- +$343.0M (+25.6%) vs. Q3 2024
- New holders
- 37
- 50 more added
- Sold out
- 15
- 44 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $3.13B |
| Q1 2026 | 203 | $2.67B |
| Q4 2025 | 197 | $3.04B |
| Q3 2025 | 168 | $2.26B |
| Q2 2025 | 152 | $1.80B |
| Q1 2025 | 157 | $1.65B |
| Q4 2024 | 152 | $1.68B |
| Q3 2024 | 132 | $1.35B |
| Q2 2024 | 121 | $1.24B |
| Q1 2024 | 130 | $1.38B |
| Q4 2023 | 112 | $1.17B |
| Q3 2023 | 91 | $934.0M |
| Q2 2023 | 90 | $848.7M |
| Q1 2023 | 45 | $309.6M |
| Q4 2022 | 35 | $215.8M |
| Q3 2022 | 44 | $43.9M |
| Q2 2022 | 51 | $43.8M |
| Q1 2022 | 57 | $39.6M |
| Q4 2021 | 62 | $93.8M |
| Q3 2021 | 62 | $103.5M |
| Q2 2021 | 55 | $165.3M |
| Q1 2021 | 49 | $346.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Disc Medicine, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | 38,459 | $2.44M | 0.00% | +9,394+32.3% | Added |
| Ensign Peak Advisors, Inc | 40,000 | $2.54M | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 40,064 | $2.54M | 0.00% | −81−0.2% | Reduced |
| Citigroup Inc | 42,635 | $2.70M | 0.00% | +27,752+186.5% | Added |
| TD Asset Management Inc | 44,932 | $2.85M | 0.00% | +4,200+10.3% | Added |
| Nuveen Asset Management, LLC | 50,121 | $3.18M | 0.00% | −44,683−47.1% | Reduced |
| Patient Square Capital LP | 56,400 | $3.58M | 1.34% | +56,400 | New |
| Bank of New York Mellon Corp | 57,261 | $3.63M | 0.00% | +4,356+8.2% | Added |
| JPMorgan Chase & Co | 61,017 | $3.87M | 0.00% | +44,762+275.4% | Added |
| Exome Asset Management LLC | 69,072 | $4.38M | 3.29% | +4,556+7.1% | Added |
| Sio Capital Management, LLC | 73,511 | $4.66M | 1.31% | −114,430−60.9% | Reduced |
| Baker Bros. Advisors LP | 77,050 | $4.88M | 0.05% | +77,050 | New |
| D. E. Shaw & Co., Inc. | 81,190 | $5.15M | 0.01% | +81,190 | New |
| Renaissance Technologies LLC | 86,420 | $5.48M | 0.01% | +86,420 | New |
| Raymond James Financial Inc | 88,002 | $5.58M | 0.00% | +88,002 | New |
| Schroder Investment Management Group | 91,490 | $5.64M | 0.01% | −1,089−1.2% | Reduced |
| UBS Asset Management Americas Inc | 93,103 | $5.90M | 0.00% | +74,454+399.2% | Added |
| Silverarc Capital Management, LLC | 110,381 | $7.00M | 1.56% | +6,519+6.3% | Added |
| Blue Owl Capital Holdings LP | 120,260 | $7.62M | 1.80% | −55,000−31.4% | Reduced |
| Pictet Asset Management Holding SA | 129,482 | $8.21M | 0.01% | −28,066−17.8% | Reduced |
| Dimensional Fund Advisors LP | 139,720 | $8.86M | 0.00% | +86,154+160.8% | Added |
| Nantahala Capital Management, LLC | 150,000 | $9.51M | 0.67% | 00.0% | Unchanged |
| Morgan Stanley | 150,024 | $9.51M | 0.00% | +80,087+114.5% | Added |
| Charles Schwab Investment Management Inc | 165,072 | $10.5M | 0.00% | +4,518+2.8% | Added |
| Goldman Sachs Group Inc | 171,810 | $10.9M | 0.00% | +244+0.1% | Added |
| Catalio Capital Management, LP | 179,815 | $11.4M | 2.49% | +179,815 | New |
| Checkpoint Capital L.P. | 185,000 | $11.7M | 5.97% | +159,457+624.3% | Added |
| Northern Trust Corp | 187,017 | $11.9M | 0.00% | +16,299+9.5% | Added |
| Logos Global Management LP | 200,000 | $12.7M | 1.48% | −735,000−78.6% | Reduced |
| Victory Capital Management Inc | 236,244 | $15.0M | 0.01% | +16,230+7.4% | Added |
| Foresite Capital Management V, LLC | 299,069 | $19.0M | 15.78% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 346,401 | $22.0M | 3.12% | +34,640+11.1% | Added |
| Adage Capital Partners GP, L.L.C. | 350,000 | $22.2M | 0.04% | −200,000−36.4% | Reduced |
| Armistice Capital, LLC | 356,000 | $22.6M | 0.52% | +196,000+122.5% | Added |
| Woodline Partners LP | 396,600 | $25.1M | 0.17% | +19,538+5.2% | Added |
| Geode Capital Management, LLC | 472,706 | $30.0M | 0.00% | −2,013−0.4% | Reduced |
| TCG Crossover Management, LLC | 486,957 | $30.9M | 3.02% | 00.0% | Unchanged |
| Saturn V Capital Management LLC | 509,406 | $32.3M | 12.65% | −1,635−0.3% | Reduced |
| Citadel Advisors LLC | 591,271 | $37.5M | 0.03% | +180,247+43.9% | Added |
| Deerfield Management Company, L.P. (Series C) | 600,515 | $38.1M | 0.72% | −422,750−41.3% | Reduced |
| State Street Corp | 768,735 | $48.7M | 0.00% | −59,175−7.1% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 983,500 | $62.4M | 7.33% | −812,235−45.2% | Reduced |
| Vanguard Group Inc | 1,068,246 | $67.7M | 0.00% | +18,716+1.8% | Added |
| Janus Henderson Group PLC | 1,217,815 | $77.2M | 0.04% | +467,988+62.4% | Added |
| Price T Rowe Associates Inc | 1,394,637 | $88.4M | 0.01% | +262,690+23.2% | Added |
| Wellington Management Group LLP | 1,395,405 | $88.5M | 0.02% | −444,821−24.2% | Reduced |
| Paradigm Biocapital Advisors LP | 1,497,720 | $95.0M | 3.30% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,754,834 | $111.3M | 4.62% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,785,571 | $113.2M | 2.35% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,859,732 | $117.9M | 0.00% | +8,579+0.5% | Added |
| FMR LLC | 1,866,248 | $118.3M | 0.01% | +1,459,434+358.7% | Added |
| Atlas Venture Life Science Advisors, LLC | 2,509,456 | $159.1M | 19.41% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −387,017−100.0% | Sold out |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −104,925−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −81,586−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −15,419−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −13,440−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −11,980−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −9,057−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −8,805−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −7,900−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −6,609−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −4,703−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Eagle Asset Management Inc | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |